Skip to main content

and
  1. Article

    Open Access

    Strategies and governance to reduce health inequalities: evidences from a cross-European survey

    The main objective of the paper is to identify the governance system related to policies to reduce health inequalities in the European regions. Considering the Action Spectrum of inequalities and the check lis...

    Sara Barsanti, Louis-Rachid Salmi, Yann Bourgueil in Global Health Research and Policy (2017)

  2. Article

    Open Access

    Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

    Recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) has a poor prognosis and the combination of cisplatin and cetuximab, with or without 5-fluorouracil, is the gold standard treatment in ...

    Francesco Caponigro, Elena Di Gennaro, Franco Ionna, Francesco Longo in BMC Cancer (2016)

  3. Article

    Open Access

    Trends in socioeconomic inequalities in mortality in small areas of 33 Spanish cities

    In Spain, several ecological studies have analyzed trends in socioeconomic inequalities in mortality from all causes in urban areas over time. However, the results of these studies are quite heterogeneous find...

    Marc Marí-Dell’Olmo, Mercè Gotsens, Laia Palència in BMC Public Health (2016)

  4. Article

    Open Access

    Trends in socioeconomic inequalities in preventable mortality in urban areas of 33 Spanish cities, 1996–2007 (MEDEA project)

    Preventable mortality is a good indicator of possible problems to be investigated in the primary prevention chain, making it also a useful tool with which to evaluate health policies particularly public health...

    Andreu Nolasco, Joaquin Moncho in International Journal for Equity in Health (2015)

  5. No Access

    Article

    Trends in Socioeconomic Inequalities in Ischemic Heart Disease Mortality in Small Areas of Nine Spanish Cities from 1996 to 2007 Using Smoothed ANOVA

    The aim of this study was to analyze the evolution of socioeconomic inequalities in mortality due to ischemic heart diseases (IHD) in the census tracts of nine Spanish cities between the periods 1996–2001 and ...

    Marc Marí-Dell’Olmo, Mercè Gotsens, Carme Borrell in Journal of Urban Health (2014)

  6. Article

    Open Access

    Do socioeconomic inequalities in mortality vary between different Spanish cities? a pooled cross-sectional analysis

    The relationship between deprivation and mortality in urban settings is well established. This relationship has been found for several causes of death in Spanish cities in independent analyses (the MEDEA proje...

    Miguel A Martinez-Beneito, Oscar Zurriaga, Paloma Botella-Rocamora in BMC Public Health (2013)

  7. Article

    Open Access

    Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

    The effect of the addition of fotemustine and/or interferon (IFN) to standard therapy with dacarbazine alone in patients with advanced malignant melanoma was investigated in a multicenter, randomized 2x2 facto...

    Antonio Daponte, Simona Signoriello, Luigi Maiorino in Journal of Translational Medicine (2013)

  8. Article

    Open Access

    Erratum to: Cancer mortality inequalities in urban areas: a Bayesian small area analysis in Spanish cities

    Rosa Puigpinós-Riera, Marc Marí-Dell'Olmo in International Journal of Health Geographics (2011)

  9. Article

    Open Access

    Cancer mortality inequalities in urban areas: a Bayesian small area analysis in Spanish cities

    Intra-urban inequalities in mortality have been infrequently analysed in European contexts. The aim of the present study was to analyse patterns of cancer mortality and their relationship with socioeconomic de...

    Rosa Puigpinós-Riera, Marc Marí-Dell'Olmo in International Journal of Health Geographics (2011)

  10. Article

    Open Access

    Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment

    High-dose interferon-alpha 2b (IFN-α 2b) is the only approved systemic therapy in the United States for the adjuvant treatment of melanoma. The study objective was to explore the immunomodulatory mechanism of ...

    Paolo A Ascierto, Maria Napolitano, Egidio Celentano in Journal of Translational Medicine (2010)

  11. Article

    Open Access

    The role of spectrophotometry in the diagnosis of melanoma

    Spectrophotometry (SPT) could represent a promising technique for the diagnosis of cutaneous melanoma (CM) at earlier stages of the disease. Starting from our experience, we further assessed the role of SPT in...

    Paolo A Ascierto, Marco Palla, Fabrizio Ayala, Ileana De Michele in BMC Dermatology (2010)

  12. Article

    Open Access

    Laparoscopic cholecystectomy for melanoma metastatic to the gallbladder: is it an adequate surgical procedure? Report of a case and review of the literature

    Only 2% to 4% of patients with melanoma will be diagnosed with gastrointestinal metastasis during the course of their disease. The most common sites of gastrointestinal metastases from melanoma include the sma...

    Ugo Marone, Corrado Caracò, Simona Losito in World Journal of Surgical Oncology (2007)

  13. Article

    Open Access

    Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

    Detection of circulating malignant cells (CMCs) through a reverse transcriptase-polymerase chain reaction (RT-PCR) assay seems to be a demonstration of systemic disease. We here evaluated the prognostic role o...

    Giuseppe Palmieri, Sabrina MR Satriano, Mario Budroni, Antonio Cossu in BMC Cancer (2006)

  14. No Access

    Article

    Socio-Economic Level, Farming Activities and Risk of Cancer in Small Areas of Southern Spain

    An ecological design was used to study the relationship between cancer incidence and both socio-economic and environmental features in Southern Spain. Twenty-four sites and 26,380 cases diagnosed in 1985–1996 ...

    Ricardo Ocaña-Riola, Carmen Sánchez-Cantalejo in European Journal of Epidemiology (2004)

  15. No Access

    Article

    Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

    Purpose: In a previous phase I study we found the MTDs of paclitaxel and cisplatin when given together weekly, with or without G-CSF support, in patients with advanced solid tumors. The present study was conducte...

    Giuseppe Frasci, Pasquale Comella, Giuseppe D'Aiuto in Breast Cancer Research and Treatment (1998)

  16. No Access

    Article

    Treatment of resistant non-Hodgkin’s lymphomas with cisplatin, etoposide, and bleomycin

    A combination of cisplatin (60 mg/m2 i.v. on day 1), etoposide (100 mg/m2 i.v. on days 1 – 3) and bleomycin (15 mg i. v. on days 1 and 8) (PEB regimen) was given every 4 weeks as salvage therapy in 10 refractory ...

    Pasquale Comella, Giuseppe Abate in Cancer Chemotherapy and Pharmacology (1990)